论文信息 - 588 Phase Ib study of the p38 inhibitor ARRY-614 with nivolumab, ipilimumab or nivolumab+ipilimumab in advanced solid tumors - 字舞流文

588 Phase Ib study of the p38 inhibitor ARRY-614 with nivolumab, ipilimumab or nivolumab+ipilimumab in advanced solid tumors

D. Davar | Amy Rose | Y. Najjar | J. Beumer | J. Luke | Roby Thomas | R. Bao | W. Gooding | D. Zandberg | A. Poklepovic | J. Urban | L. Villaruz | Xin Gao | J. Kirkwood | Ryan C Augustin | S. Brodeur | Amy Goodman | Darcy Ploucha